The U.S. Food and Drug Administration has also updated their compliance program to monitor additional mycotoxins of regulatory interest in human foods, specifically T-2/HT-2 toxins and zearalenone. The updated compliance program also reflects the transition by FDA regulatory laboratories to a multi-mycotoxin method for analysis. In both cases this presents opportunities for R-Biopharm Rhône’s single and multi-toxin Fusarium products. These changes mean businesses operating in food and feed industries must ensure compliance with these stricter regulations.
 
In 2024, the European Union introduced stricter legislation, lowering the maximum legislative levels of deoxynivalenol (DON) and introducing legislation for T-2 and HT-2 toxins. These changes impact producers, processors, and laboratories responsible for mycotoxin testing, requiring adjustments in quality control strategies to remain compliant.
 
T-2 & HT-2 toxins

T-2 and HT-2 toxins were previously monitored using guideline levels rather than strict legislative limits. The latest regulations introduce mandatory maximum thresholds for a range of food products, including cereal grains, processed milling products, and cereal-based foods, with specific limits varying by category. The new maximum levels are: